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We report 3 cases of spotted fever group rickettsial in-
fection (presumed Queensland tick typhus) in residents of 
northern Queensland, Australia, who had unusually severe 
clinical manifestations. Complications included renal failure, 
purpura fulminans, and severe pneumonia. Clinical illness 
caused by Rickettsia australis may not be as benign as pre-
viously described.
Queensland tick typhus (QTT) is caused by Rickettsia australis, an obligate intracellular organism that is 
transmitted to humans through the bite of 1 of 2 known 
tick vectors, Ixodes holocyclus or I. tasmani (1). The dis-
ease occurs along the eastern coast of Australia, including 
Queensland. QTT is considered to be a mild illness. Clinical 
features are fever, headache, and myalgia. An eschar may 
be seen at the site of the tick bite, and a maculopapular or 
vesicular skin rash is usually noted. Patients usually make 
an uncomplicated recovery. We report 3 cases of presumed 
QTT in Australia that were unusually severe and showed 
manifestations that, to our knowledge, were previously un-
reported with this disease.
The Cases
Case 1
The fi rst case occurred in a 40-year-old woman from 
Kuranda, Queensland, with a 1-week history of fever, my-
algia, headache, and dry cough. She had sustained tick bites 
to the back and leg while planting trees. She was febrile 
(temperature 38.1°C). A widespread maculopapular rash 
with a minor petechial component was present. No eschars 
were found. Renal dysfunction was evident by blood tests 
(Table). A provisional diagnosis of leptospirosis was made, 
and she was treated with intravenous penicillin. Urea and 
creatinine levels continued to increase over 3 days to 14.8 
mmol/L and 300 μmol/L, respectively, despite administra-
tion of intravenous fl uids. She showed no dehydration or 
hypotension. Urinalysis showed 1+ proteinuria only. The 
patient’s clinical condition improved slowly over 7 days. 
The rash had a more noticeable petechial component at this 
stage of the disease. The patient was discharged on day 
7 and given a 5-day course of oral doxycycline, 100 mg, 
twice a day. She had fully recovered on subsequent follow- 
up. A diagnosis of QTT was made retrospectively on the 
basis of serologic results.
Case 2
The second case occurred in a 69-year-old woman 
from Innisfail, Queensland, who was hospitalized with a 
2-week history of fever, myalgia, neck pain, and confusion. 
She was febrile (temperature 39.2°C) and had tachycardia 
(140 beats/min). Multiorgan failure, purpura fulminans, 
and digital necrosis developed over a 2-day period, and she 
was transferred to an intensive care unit. Intubation and 
ventilation were required. She had widespread cutaneous 
and digital necrosis. There were no eschars or lymphade-
nopathy. Prothrombin time was 22 s (normal range 8–14 
s), activated partial thromboplastin time was 53 s (normal 
range 25–38 s), and fi brinogen level was 1.6 g/L (normal 
range 1.5–4.0 g/L). The latex D dimer titer was 8 (normal 
<1). Results of a PCR for Neisseria meningitidis in blood 
and an extensive screen for primary vasculitides and pro-
thrombotic disorders were negative. A skin biopsy speci-
men showed vessel thrombosis and no evidence of vasculi-
tis, which is consistent with purpura fulminans. 
Treatment included broad-spectrum antimicrobial 
drugs and doxycycline. Clinical recovery was prolonged, 
and she required temporary renal dialysis. Fourteen digital 
amputations were performed on her hands and feet (Fig-
ure 1). There was serologic evidence of R. australis infec-
tion. She lived in a house that bordered bushland and had 
received tick bites. However, she could not recall her last 
exposure. Tissue from the skin biopsy specimen was tested 
by PCR with primers against the rickettsial 17-kDa gene 
(2), and immunohistochemical analysis was performed 
with polyclonal rabbit antisera against spotted fever group 
(SFG)  rickettsiae. Both tests showed negative results.
Case 3
The third case occurred in a 45-year-old man from 
Deeral, Queensland, who was seen with headache, malaise, 
and vomiting 10 days after a tick bite. He also had a cough, 
dyspnea, and insulin-dependent diabetes. He was em-
ployed working on rural roads. He was febrile (temperature 
38.2°C) and had tachycardia (145 beats/min) and tachypnea 
(40 breaths/min). He required 15 L/min oxygen by mask to 
maintain oxygenation. There was a fi ne petechial rash and 
left inguinal lymphadenopathy. A chest radiograph showed 
bilateral interstitial infi ltrates (Figure 2). Over the ensuing 
hours, respiratory failure developed, and he required intu-
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bation and ventilation. Twelve hours after admission, his 
arterial blood gas results were pH 7.32, pO2 59 mmHg, and 
pCO2 55 mmHg on 100% oxygen while ventilated. His cre-
atinine level increased to 180 μmol/L over the fi rst 2 days 
and then slowly returned to normal. He was given broad-
spectrum antimicrobial drugs, including doxycycline, on 
the day of admission. Treatment with doxycycline contin-
ued for 7 days. His recovery was marked by gross general-
ized edema. Serologic results were diagnostic for infection 
with R. australis. He was ventilated for 16 days and spent 
3 weeks in the intensive care unit. He returned to work 2 
months after admission.
Conclusions
The clinical features of QTT have been described in 
2 reviews (1,3). One review of 62 cases included patients 
from Flinders Island in the Bass Strait, an area now known 
to be endemic for a new rickettsia in the SFG, Rickettsia 
honei (4). These reviews describe an illness marked by 
malaise, headache, and myalgia. A maculopapular rash ap-
pears in most patients. The rash may become petechial or 
vesicular in some cases. An eschar is seen in up to half 
the cases and lymphadenopathy in <70%. Less common 
clinical manifestations include joint pain, splenomegaly, 
cough, conjunctivitis, sore throat, nausea, abdominal pain, 
and photophobia. One patient had minor renal dysfunction 
(1). Mild-to-moderate elevation of hepatic transaminase 
levels is common.
One fatal case of QTT has been described in a 68-
year-old man from northern Queensland (5). His illness 
was clinically marked by progressive renal failure, bilateral 
pulmonary infi ltrates, acidosis, abnormal liver function test 
results, thrombocytopenia, and hypoprothrombinemia.
The fi rst patient described in this report had moder-
ate renal impairment, which is commonly associated with 
leptospirosis. Her renal dysfunction did not improve with 
rehydration but had fully resolved when her condition 
was reevaluated 3 weeks after hospital discharge. Renal 
failure is a feature of other spotted fever rickettsial ill-
nesses. Rocky Mountain spotted fever (RMSF), which 
is caused by R. rickettsii, is associated with a multifocal 
perivascular interstitial nephritis. Renal dysfunction is 
believed to be a consequence of hypovolemia secondary 
to rickettsial disease–induced alterations in capillary per-
meability (6,7). Renal failure has also been recorded as a 
complication of infection with R. conorii (Mediterranean 
spotted fever) (8).
The second patient had a clinical picture usually asso-
ciated with overwhelming bacterial infection. N. meningiti-
dis was considered a possible cause of her illness. Howev-
er, her 2-week illness before deterioration was not typical. 
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Table. Laboratory test results in 3 severe cases of infection with Rickettsia australis, Australia 
Test Case 1 Case 2 Case 3 Reference range 
Hemoglobin, g/L 124 130 142 115–160
Neutrophil count, cells/L 6.19 11.4 8.8 2.00–8.00 × 109
Lymphocyte count, cells/L 0.39 0.4 1.58 1.00–4.00 × 109
Platelet count, cells/L 63 30 167 140–400 × 109
Sodium, mmol/L 131 135 139 135–145
Urea, mmol/L 9.8 27.8 5.0 3.0–8.0
Creatinine, μmol/L 190 430 100 70–120
Bilirubin, μmol/L 28 105 41 <20
Alkaline phosphatase, U/L 295 250 587 30–120
Gamma-glutamyl transferase, U/L 205 121 877 <50
Alanine aminotransferase, U/L 131 47 404 <40
Aspartate aminotransferase, U/L 178 152 417 <35
Leptospirosis immunoglobulin M Negative Negative Negative
Duration of symptoms before 
doxycycline treatment, d 
17 14 10
R. australis antibody titer* Negative to 2,048 
over 9 d 
64–1,024 over 8 d Negative to >1,024 
over 9 d 
Negative <64 
Positive >64
*By immunofluorescence.
Figure 1. Digital gangrene in a patient (case 2) with Rickettsia 
australis infection.
DISPATCHES
Serologic results were diagnostic for infection with R. aus-
tralis. Purpura fulminans has been described in RMSF. In a 
review of cases of gangrene complicating this infection, 6 
cases with remarkable similarities to our second case were 
described (9).
The predominant clinical complication of the third pa-
tient was pulmonary involvement. This characteristic has 
only been described once in QTT (5). Pulmonary involve-
ment has been described in RMSF, in which the pathology 
changes are thought to be related to noncardiogenic pul-
monary edema consequent to capillary endothelial damage 
(10,11).
There are 12 described rickettsiae of the spotted group 
(12). RMSF is associated with a mortality rate of 7%, even 
with treatment (5), and R. conorii has been associated with 
severe disease and fatal cases. Other rickettsiae are consid-
ered to cause mild illness. 
The 3 cases described here were seen over a 4-year 
period at Cairns Base Hospital in northern Queensland. We 
are aware of 2 other cases seen at other hospitals, 1 com-
plicated by renal failure, confusion, abnormal coagulation 
test results, and impaired gas exchange, and the other with 
severe pneumonia (P. Marshall, R. Miller, pers. comm.). 
Although QTT is a mild disease in most patients, its 
diagnosis should now be considered in patients who reside 
in or visit the rickettsial disease–endemic area of eastern 
coastal Australia and are hospitalized with renal failure or 
impaired pulmonary function. Delays in seeking treatment 
may have contributed to illness severity in 2 of our patients. 
Given the serologic cross-reactivity between members of 
the SFG rickettsia, it cannot be assumed that all cases de-
scribed were caused by R. australis. Another rickettsia of 
the SFG has been recently described in northern Queensland 
(13), and distinguishing between species will be important 
in future studies. 
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Figure 2. Radiograph showing pneumonia in a patient (case 3) with 
Rickettsia australis infection.
